EMEA-000883-PIP01-10-M05
Key facts
| Invented name |
Trecondi
|
| Active substance |
Treosulfan
|
| Therapeutic area |
|
| Decision number |
P/0346/2020
|
| PIP number |
EMEA-000883-PIP01-10-M05
|
| Pharmaceutical form(s) |
Powder for solution
|
| Condition(s) / indication(s) |
Conditioning treatment prior to haematopoietic-progenitor-cell transplantation
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
medac Gesellschaft für klinische Spezialpräparate mbH
Germany |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000883-PIP01-10-M05
|
| Compliance opinion date |
25/03/2022
|
| Compliance outcome |
positive
|